Hepatic Decompensation and Serious Adverse Events in Liver Transplant Recipients Treated with Sofosbuvir-containing Regimens for Recurrent HCV Infection

被引：0

作者：

Patel, Neal M. ^{[1
]}

Bichoupan, Kian ^{[1
]}

Ku, Lawrence ^{[1
]}

Yalamanchili, Rachana ^{[1
]}

Harty, Alyson ^{[1
]}

Gardenier, Donald ^{[1
]}

Ng, Michel ^{[1
]}

Motamed, David B. ^{[1
]}

Khaitova, Viktoriya ^{[1
]}

Bach, Nancy ^{[1
]}

Chang, Charissa Y. ^{[1
]}

Grewal, Priya ^{[1
]}

Bansal, Meena B. ^{[1
]}

Agarwal, Ritu ^{[1
]}

Liu, Lawrence ^{[1
]}

Im, Gene Y. ^{[1
]}

Leong, Jennifer ^{[1
]}

Kim-Schluger, Leona ^{[1
]}

Odin, Joseph A. ^{[1
]}

Ahmad, Jawad ^{[1
]}

Friedman, Scott L. ^{[1
]}

Dieterich, Douglas ^{[1
]}

Schiano, Thomas D. ^{[1
]}

Perumalswami, Ponni V. ^{[1
]}

Branch, Andrea D. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Liver Dis, Parsippany, NJ USA

来源：

HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1185

引用

页码：795A / 796A

页数：2

共 50 条

[41] The Use of Sofosbuvir (SOF)-Containing Direct Antiviral Agents (DAA)-Based Regimens Requires Increase in Tacrolimus (Tac) Doses in Kidney Transplant (KT) Recipients with Hepatitis C Virus (HCV) Infection.
Fernandez, N. Polanco
Santiago, A. Garcia
Ruiz, M. Fernandez
Munoz, R.
Vazquez, C. Alvarez
Hernandez, A.
Mercado, V.
Monte, E. Gonzalez
Fernandez, I.
Aguado, J.
Praga, M.
Andres, A.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 230 - 231
[42] SLOW HCV KINETICS FOLLOWING SOFOSBUVIR plus RIBAVIRIN ADMINISTRATION IN REAL-LIFE SETTING OF LIVER TRANSPLANT RECIPIENTS WITH SEVERE RECURRENT HEPATITIS C
Cento, V.
Donato, M. F.
Lenci, I.
Rendina, M.
Milana, M.
Di Maio, V. C.
Monico, S.
Aragri, M.
Alfieri, R.
Abedrabbo, A.
Sforza, D.
Manuelli, M.
Mameli, L.
Sorbo, M. C.
Canu, R.
Ponti, M. L.
Chiala, C.
Malinverno, F.
Marenco, S.
Milanesi, L.
Picciotto, A.
Rossi, G.
Di Leo, A.
Tisone, G.
Zamboni, F.
Ganga, R.
Colombo, M.
Perno, C. F.
Angelico, M.
Ceccherini-Silberstein, F.
[J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S683 - S683
[43] Choice of calcineurin inhibitor as well as genotype incluence response to antiviral therapy in liver transplant recipients treated for recurrent HCV.
Lilly, Leslie B.
Selzner, Nazia
Wong, Philip
Therapondos, George
Levy, Gary A.
Cattral, Mark S.
Greig, Paul D.
McGilvray, Ian
Grant, David R.
Girgrah, Nigel
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 240 - 240
[44] Improved survival in liver transplant recipients (LT) treated for recurrent hepatitis C (HCV) is seen in both relapsers and in sustained responders
Lilly, Les
Selzner, Nazia
Therapondos, George
Renner, Eberhard L.
Selzner, Marcus
McGilvray, Ian
Greig, Paul D.
Cattral, Mark S.
Grant, David R.
Levy, Gary A.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 612 - 612
[45] ACUTE VANISHING BILE-DUCT SYNDROME AFTER INTERFERON THERAPY FOR RECURRENT HCV INFECTION IN LIVER-TRANSPLANT RECIPIENTS
DOUSSET, B
CONTI, F
HOUSSIN, D
CALMUS, Y
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (16): : 1160 - 1161
[46] Early steatosis in transplant recipients with recurrent HCV infection is associated with early short term use of steroids and delayed progression of hepatic fibrosis
Aneelico, M
Palmieri, G
Battista, S
Casarelli, F
Di Paolo, D
Petrolati, A
Ciceroni, C
Lionetti, R
Tisone, G
[J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 35 - 35
[47] Short-term use of steroids in transplant recipients with recurrent HCV infection is associated with early steatosis and slow progression of hepatic fibrosis
Angelico, M
Palmieri, G
Battista, S
Casarelli, F
Di Paolo, D
Piccolo, P
Petrolati, A
Cicerone, C
Lionetti, R
Tisone, G
[J]. GASTROENTEROLOGY, 2003, 124 (04) : A731 - A732
[48] Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection
Grant, Jennifer L.
Hawkins, Claudia
Brooks, Hannah
Palella, Frank J., Jr.
Koppe, Sean W. P.
Abecassis, Michael M.
Stosor, Valentina
[J]. AIDS, 2016, 30 (01) : 93 - 98
[49] Time Course of Hepatic Graft Function Improvement After Ledipasivir/Sofosbuvir Treatment in Liver Transplant Recipients with HCV and Fibrosis or Cirrhosis Who Achieved SVR.
Helmke, S.
O'Leary, J.
Burton, J.
Cookson, M.
Lauriski, S.
Trotter, J.
McHutchison, J.
Everson, G.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 297 - 297
[50] DAA-Containing Regimens for the Treatment of Recurrent HCV Infection After Liver Transplantation Are Safe and Effective Regardless of Genotype and Fibrosis Stage
Brahmbhatt, Rinjal
Rudloff, Robyn
McCashland, Timothy
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S1053 - S1053

← 1 2 3 4 5 →